ALLP suspends Phase III cardiac study

Alliance Pharmaceutical (ALLP) said it voluntarily suspended enrollment in a Phase III study of its Oxygent perflubron blood

Read the full 182 word article

How to gain access

Continue reading with a
two-week free trial.